ARCHIVES

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Letter to the Editor: “We Will Not Be Distracted From Our Mission”

February 1, 2013

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 12, 1990

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008